Search Results | Diabetes Care | American Diabetes Association

1-19 of 19

Sort by

Sort Order Select

Meeting Abstracts

A 12-h intravenous insulin infusion restores the beta-cell response torpidity to sulfonylureas in patients affected by type 2 diabetes.

D Sinagra, D Greco, M C Amato, G D'Acquisto, A Galluzzo

Diabetes Care 2000;23(12):1857–1858

DOI: https://doi.org/10.2337/diacare.23.12.1857

Published: 01 December 2000

View article

Meeting Abstracts

Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.

K C Chiu, P Cohan, N P Lee, L M Chuang

Diabetes Care 2000;23(9):1353–1358

DOI: https://doi.org/10.2337/diacare.23.9.1353

Published: 01 September 2000

View article

Meeting Abstracts

GAD65 autoantibodies, beta-cell function, and insulin resistance in Japanese-Brazilian adults. Centro de Estudos da Comunidade Nipo Brasileira de Bauru.

A P França, D L Bezerra, L J Franco, S A Dib

Diabetes Care 2000;23(9):1437–1439

DOI: https://doi.org/10.2337/diacare.23.9.1437

Published: 01 September 2000

View article

Meeting Abstracts

European Association for the Study of Diabetes Annual Meeting, 1999: the beta-cell, autoimmunity, and insulin resistance.

Z T Bloomgarden

Diabetes Care 2000;23(8):1192–1196

DOI: https://doi.org/10.2337/diacare.23.8.1192

Published: 01 August 2000

View article

Meeting Abstracts

Diabetes-related autoantibodies and the selection of subjects for trials of therapies to preserve pancreatic beta-cell function in recent-onset type 1 diabetes.

J Dupré, J L Mahon

Diabetes Care 2000;23(8):1057–1058

DOI: https://doi.org/10.2337/diacare.23.8.1057

Published: 01 August 2000

View article

Meeting Abstracts

Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function.

E J Novak, E Ortqvist, E Nord, L Edwall, C S Hampe, L Bekris, B E Persson, A Lernmark

Diabetes Care 2000;23(7):1019–1021

DOI: https://doi.org/10.2337/diacare.23.7.1019

Published: 01 July 2000

View article

Meeting Abstracts

Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.

T Vilsbøll, M B Toft-Nielsen, T Krarup, S Madsbad, B Dinesen, J J Holst

Diabetes Care 2000;23(6):807–812

DOI: https://doi.org/10.2337/diacare.23.6.807

Published: 01 June 2000

View article

Meeting Abstracts

Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.

S C Elbein, K Wegner, S E Kahn

Diabetes Care 2000;23(2):221–227

DOI: https://doi.org/10.2337/diacare.23.2.221

Published: 01 February 2000

View article

Meeting Abstracts

Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.

M Fukui, N Nakamura, K Nakano, M Kondo

Diabetes Care 1999;22(10):1758–1759

DOI: https://doi.org/10.2337/diacare.22.10.1758

Published: 01 October 1999

View article

Meeting Abstracts

Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function

A Shimada, T Maruyama, R Suzuki, J Morimoto, O Funae, A Kasuga, T Saruta

Diabetes Care 1999;22(10):1759

DOI: https://doi.org/10.2337/diacare.22.10.1759

Published: 01 October 1999

View article

Meeting Abstracts

Lack of association between early childhood immunizations and beta-cell autoimmunity.

P M Graves, K J Barriga, J M Norris, M R Hoffman, L Yu, G S Eisenbarth, M Rewers

Diabetes Care 1999;22(10):1694–1697

DOI: https://doi.org/10.2337/diacare.22.10.1694

Published: 01 October 1999

View article

Meeting Abstracts

Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.

M E Røder, B Dinesen, S G Hartling, P Houssa, H Vestergaard, F Sodoyez-Goffaux, C Binder

Diabetes Care 1999;22(4):609–614

DOI: https://doi.org/10.2337/diacare.22.4.609

Published: 01 April 1999

View article

Meeting Abstracts

T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report.

A Shimada, Y Imazu, S Morinaga, O Funae, A Kasuga, Y Atsumi, K Matsuoka

Diabetes Care 1999;22(4):615–617

DOI: https://doi.org/10.2337/diacare.22.4.615

Published: 01 April 1999

View article

Meeting Abstracts

Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.

G Bruno, A De Salvia, R Arcari, M Borra, N Grosso, Q Carta, M Trovati, M Veglio, G Pagano

Diabetes Care 1999;22(1):50–55

DOI: https://doi.org/10.2337/diacare.22.1.50

Published: 01 January 1999

View article

Journal Articles

Progressive Autoimmune Beta Cell Insufficiency: Occurrence in the Absence of High-Risk HLA Alleles DR3, DR4

George S Eisenbarth, M.D., Ph.D., S Srikanta, M.D., Ellen Fleischnick, M.D., Om P Ganda, M.D., Richard A Jackson, M.D., Stuart J Brink, M.D., J Stuart Soeldner, M.D., Edmond J Yunis, M.D., Chester Alper, M.D.

Diabetes Care 1985;8(5):477–480

DOI: https://doi.org/10.2337/diacare.8.5.477

Published: 01 September 1985

View article

Journal Articles

Pathophysiology of Beta Cell Failure After Prolonged Remission of Insulin-dependent Diabetes Mellitus (IDDM)

Daniel Drucker, M.D., Bernard Zinman, M.D.

Diabetes Care 1984;7(1):83–87

DOI: https://doi.org/10.2337/diacare.7.1.83

Published: 01 January 1984

View article

Journal Articles

Urinary C-Peptide as a Measure of Beta-Cell Function After a Mixed Meal in Healthy Subjects: Comparison of Four-hour Urine C-Peptide with Serum Insulin and Plasma C-Peptide

Byron J Hoogwerf, MD, Jose J Barbosa, MD, John P Bantle, MD, Dawn Laine, RD, Frederick C Goetz, MD

Diabetes Care 1983;6(5):488–492

DOI: https://doi.org/10.2337/diacare.6.5.488

Published: 01 September 1983

View article

Journal Articles

Reproducibility of Insulin Dosage on Consecutive Days of Blood Glucose Control by an Artificial Beta-Cell in Brittle Diabetic Patients

Waldemar Bruns, Hans Bombor, Erich Jutzi, Klaus-Peter Ratzmann, Bernd Schulz, Peter Abel, Uwe Fischer

Diabetes Care 1983;6(2):112–117

DOI: https://doi.org/10.2337/diacare.6.2.112

Published: 01 March 1983

View article

Journal Articles

Hyperinsulinism Complicating Control of Diabetes Mellitus by an Artificial Beta-Cell

David L Horwitz, Adina Zeidler, Boas Gonen, Jonathan B Jaspan

Diabetes Care 1980;3(2):274–277

DOI: https://doi.org/10.2337/diacare.3.2.274

Published: 01 March 1980

View article

NARROW

A 12-h intravenous insulin infusion restores the beta-cell response torpidity to sulfonylureas in patients affected by type 2 diabetes.

Insulin sensitivity differs among ethnic groups with a compensatory response in beta-cell function.

GAD65 autoantibodies, beta-cell function, and insulin resistance in Japanese-Brazilian adults. Centro de Estudos da Comunidade Nipo Brasileira de Bauru.

European Association for the Study of Diabetes Annual Meeting, 1999: the beta-cell, autoimmunity, and insulin resistance.

Diabetes-related autoantibodies and the selection of subjects for trials of therapies to preserve pancreatic beta-cell function in recent-onset type 1 diabetes.

Stability of disease-associated antibody titers in pregnant women with type 1 diabetes with or without residual beta-cell function.

Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.

Reduced beta-cell compensation to the insulin resistance associated with obesity in members of caucasian familial type 2 diabetic kindreds.

Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.

Anti-GAD65 antibody titer may be important in assessing T-cell response in anti-GAD65+ diabetes with residual beta-cell function

Lack of association between early childhood immunizations and beta-cell autoimmunity.

Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.

T-cell insulitis found in anti-GAD65+ diabetes with residual beta-cell function. A case report.

Clinical, immunological, and genetic heterogeneity of diabetes in an Italian population-based cohort of lean newly diagnosed patients aged 30-54 years. Piedmont Study Group for Diabetes Epidemiology.

Progressive Autoimmune Beta Cell Insufficiency: Occurrence in the Absence of High-Risk HLA Alleles DR3, DR4

Pathophysiology of Beta Cell Failure After Prolonged Remission of Insulin-dependent Diabetes Mellitus (IDDM)

Urinary C-Peptide as a Measure of Beta-Cell Function After a Mixed Meal in Healthy Subjects: Comparison of Four-hour Urine C-Peptide with Serum Insulin and Plasma C-Peptide

Reproducibility of Insulin Dosage on Consecutive Days of Blood Glucose Control by an Artificial Beta-Cell in Brittle Diabetic Patients

Hyperinsulinism Complicating Control of Diabetes Mellitus by an Artificial Beta-Cell

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only